JP Morgan Maintains Neutral on Imax, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst David Karnovsky has maintained a Neutral rating on Imax (NYSE:IMAX) and lowered the price target from $20 to $17.
February 06, 2024 | 7:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan analyst David Karnovsky maintains a Neutral rating on Imax and lowers the price target from $20 to $17.
The reduction in price target by JP Morgan, a major financial institution, could lead to a negative short-term sentiment among investors, potentially causing a decrease in IMAX's stock price. The maintenance of a Neutral rating indicates that the analyst sees limited upside or downside potential from the current price level, but the lowering of the price target suggests a revision of the expected future performance of the company.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100